Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis

The aim of this study was to assess the effect of Adalimumab on different immune parameters in patients with RA. Adalimumab was administered (40 mg every other week for 26 weeks) to eight patients with RA that were refractory to conventional drug therapy. Peripheral blood samples were obtained at da...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vigna-Pérez, M, Abud-Mendoza, C, Portillo-Salazar, H, Alvarado-Sánchez, B, Cuevas-Orta, E, Moreno-Valdés, R, Baranda, L, Paredes-Saharopulos, O, González-Amaro, R
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2005
Témata:
Clinical Studies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809428/
https://ncbi.nlm.nih.gov/pubmed/15996202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2005.02859.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky